To include your compound in the COVID-19 Resource Center, submit it here.

Dermira gains on DRM01 acne data

Dermira Inc. (NASDAQ:DERM) gained $4.23 (17%) to $28.69 on Tuesday after it said the highest dose of topical DRM01 given twice daily met all

Read the full 244 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE